233 related articles for article (PubMed ID: 38232702)
41. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
[TBL] [Abstract][Full Text] [Related]
42. Proteogenomic interrogation of cancer cell lines: an overview of the field.
Tsang O; Wong JWH
Expert Rev Proteomics; 2021 Mar; 18(3):221-232. PubMed ID: 33877947
[No Abstract] [Full Text] [Related]
43. Proteogenomics: concepts, applications and computational strategies.
Nesvizhskii AI
Nat Methods; 2014 Nov; 11(11):1114-25. PubMed ID: 25357241
[TBL] [Abstract][Full Text] [Related]
44. Proteomic and genetic approaches identify Syk as an AML target.
Hahn CK; Berchuck JE; Ross KN; Kakoza RM; Clauser K; Schinzel AC; Ross L; Galinsky I; Davis TN; Silver SJ; Root DE; Stone RM; DeAngelo DJ; Carroll M; Hahn WC; Carr SA; Golub TR; Kung AL; Stegmaier K
Cancer Cell; 2009 Oct; 16(4):281-94. PubMed ID: 19800574
[TBL] [Abstract][Full Text] [Related]
45. Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes.
Casado P; Rio-Machin A; Miettinen JJ; Bewicke-Copley F; Rouault-Pierre K; Krizsan S; Parsons A; Rajeeve V; Miraki-Moud F; Taussig DC; Bödör C; Gribben J; Heckman C; Fitzgibbon J; Cutillas PR
Signal Transduct Target Ther; 2023 Feb; 8(1):80. PubMed ID: 36843114
[TBL] [Abstract][Full Text] [Related]
46. Molecular biomarkers in acute myeloid leukemia.
Prada-Arismendy J; Arroyave JC; Röthlisberger S
Blood Rev; 2017 Jan; 31(1):63-76. PubMed ID: 27639498
[TBL] [Abstract][Full Text] [Related]
47. [Molecular and cytogenetic prognostic factors in acute myeloid leukemia (AML)].
Zmorzyński S; Filip AA; Koczkodaj D; Michalak M
Postepy Hig Med Dosw (Online); 2011 Mar; 65():158-66. PubMed ID: 21502692
[TBL] [Abstract][Full Text] [Related]
48. A single-cell survey of cellular hierarchy in acute myeloid leukemia.
Wu J; Xiao Y; Sun J; Sun H; Chen H; Zhu Y; Fu H; Yu C; E W; Lai S; Ma L; Li J; Fei L; Jiang M; Wang J; Ye F; Wang R; Zhou Z; Zhang G; Zhang T; Ding Q; Wang Z; Hao S; Liu L; Zheng W; He J; Huang W; Wang Y; Xie J; Li T; Cheng T; Han X; Huang H; Guo G
J Hematol Oncol; 2020 Sep; 13(1):128. PubMed ID: 32977829
[TBL] [Abstract][Full Text] [Related]
49. Comparative proteomic analysis of patients with acute myeloid leukemia before and after induction therapy.
Restrepo-Rodríguez L; Prada-Arismendy J; Castillo E; Rothlisberger S
Cancer Biomark; 2023; 37(4):227-235. PubMed ID: 37302023
[TBL] [Abstract][Full Text] [Related]
50. A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia.
Zhang HB; Sun ZK; Zhong FM; Yao FY; Liu J; Zhang J; Zhang N; Lin J; Li SQ; Li MY; Jiang JY; Cheng Y; Xu S; Cheng XX; Huang B; Wang XZ
Lipids Health Dis; 2022 Aug; 21(1):79. PubMed ID: 36002858
[TBL] [Abstract][Full Text] [Related]
51. Identification of new protein coding sequences and signal peptidase cleavage sites of Helicobacter pylori strain 26695 by proteogenomics.
Müller SA; Findeiß S; Pernitzsch SR; Wissenbach DK; Stadler PF; Hofacker IL; von Bergen M; Kalkhof S
J Proteomics; 2013 Jun; 86():27-42. PubMed ID: 23665149
[TBL] [Abstract][Full Text] [Related]
52. Genomic Classification and Prognosis in Acute Myeloid Leukemia.
Papaemmanuil E; Gerstung M; Bullinger L; Gaidzik VI; Paschka P; Roberts ND; Potter NE; Heuser M; Thol F; Bolli N; Gundem G; Van Loo P; Martincorena I; Ganly P; Mudie L; McLaren S; O'Meara S; Raine K; Jones DR; Teague JW; Butler AP; Greaves MF; Ganser A; Döhner K; Schlenk RF; Döhner H; Campbell PJ
N Engl J Med; 2016 Jun; 374(23):2209-2221. PubMed ID: 27276561
[TBL] [Abstract][Full Text] [Related]
53. Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines.
Aasebø E; Vaudel M; Mjaavatten O; Gausdal G; Van der Burgh A; Gjertsen BT; Døskeland SO; Bruserud O; Berven FS; Selheim F
Proteomics; 2014 Sep; 14(17-18):1971-6. PubMed ID: 25044641
[TBL] [Abstract][Full Text] [Related]
54. The genomics of acute myeloid leukemia in children.
Conneely SE; Rau RE
Cancer Metastasis Rev; 2020 Mar; 39(1):189-209. PubMed ID: 31925603
[TBL] [Abstract][Full Text] [Related]
55. Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells.
Darici S; Jørgensen HG; Huang X; Serafin V; Antolini L; Barozzi P; Luppi M; Forghieri F; Marmiroli S; Zavatti M
Adv Biol Regul; 2023 Aug; 89():100974. PubMed ID: 37245251
[TBL] [Abstract][Full Text] [Related]
56. Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach.
Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829
[TBL] [Abstract][Full Text] [Related]
57. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
58. Hematopoietic niche drives FLT3-ITD acute myeloid leukemia resistance to quizartinib
Dumas PY; Naudin C; Martin-Lannerée S; Izac B; Casetti L; Mansier O; Rousseau B; Artus A; Dufossée M; Giese A; Dubus P; Pigneux A; Praloran V; Bidet A; Villacreces A; Guitart A; Milpied N; Kosmider O; Vigon I; Desplat V; Dusanter-Fourt I; Pasquet JM
Haematologica; 2019 Oct; 104(10):2017-2027. PubMed ID: 30923103
[TBL] [Abstract][Full Text] [Related]
59. Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia.
Gebru MT; Wang HG
J Hematol Oncol; 2020 Nov; 13(1):155. PubMed ID: 33213500
[TBL] [Abstract][Full Text] [Related]
60. Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia.
Beneyto-Calabuig S; Merbach AK; Kniffka JA; Antes M; Szu-Tu C; Rohde C; Waclawiczek A; Stelmach P; Gräßle S; Pervan P; Janssen M; Landry JJM; Benes V; Jauch A; Brough M; Bauer M; Besenbeck B; Felden J; Bäumer S; Hundemer M; Sauer T; Pabst C; Wickenhauser C; Angenendt L; Schliemann C; Trumpp A; Haas S; Scherer M; Raffel S; Müller-Tidow C; Velten L
Cell Stem Cell; 2023 May; 30(5):706-721.e8. PubMed ID: 37098346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
